Accommodating IOLs

Dr Arun C. Gulani explains how his corneal surface technique offers a contrast to cutting procedures without risk, pain or drama.

The announcement represents the first FDA-approved, fixed-combination of tropicamide and phenylephrine for mydriasis, according to the company.

The company’s CT Lucia 621P monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimised visual outcomes.

The atropine drops did not cause significant changes in the near vision or the pupillary size, according to study investigators.

Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.

As the company marks its 40-year anniversary, the new rebranding will become official on March 10, 2023, and will be followed by the introduction of new products.